Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.

Henry T Peng Shawn G Rhind Andrew N Beckett

Published in: JMIR public health and surveillance (2021)

There is developing support for CP therapy, particularly for patients who are critically ill or mechanically ventilated and resistant to antivirals and supportive care. These studies provide important lessons that should inform the planning of well-designed RCTs to generate more robust knowledge for the efficacy of CP in patients with COVID-19. Future research is necessary to fill the knowledge gap regarding prevention and treatment for patients with COVID-19 with CP while other therapeutics are being developed.

Keyphrases

healthcare
end stage renal disease
coronavirus disease
intensive care unit
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
acute respiratory distress syndrome
pain management
bone marrow
chronic pain
replacement therapy